Transurethral surgery for bladder transitional cell carcinoma with benign prostatic hyperplasia (BPH)

To evaluated the effect of simultaneous transurethral resection of bladder tumor (TURBT) and benign prostatic hyperplasia (TUVP) on recurrences at the bladder neck and prostatic urethra. The clinical data of 54 cases of patients with bladder transitional cell carcinoma and BPH were retrospectively reviewed .Among the patients, 32 had undergone TURBt and TUVP at the same time (group A), and the rest 22 had undergone TURBt alone (group B). The following up period ranged from 6~36 months. The recurrence occurred to 4 cases in group A without implancation at the bladder neck and prostatic urethra and no distance metastase. The recurrence occurred to 3 of 22 in group B. Recurrences appeared within an average of 13.8 months, that was within 8 month, 14 month, 16 month and 19 month in group A and 5 month, 17 month and 18 month in group B respectively. [Conclusions] Our data indicate that simultaneous TURBT and TUVP do not negatively affect tumor implancation at the bladder neck and prostatic urethra, and is a safe and effective alternative treatment.